CGM proposes dividend on prior year’s level to be passed at virtual AGM in May
|
EQS-News: CompuGroup Medical SE & Co. KGaA
/ Key word(s): Dividend/AGM/EGM
CGM proposes dividend on prior year’s level to be passed at virtual AGM in May
Koblenz. Due to the positive experiences with the virtual format and to make it easier for international investors to participate without additional travel expenses and an associated reduction in CO2 emissions, CompuGroup Medical SE & Co. KGaA (CGM) will hold its Annual General Meeting on May 17 again virtually this year. The new virtual AGM format will enable a direct interaction between shareholders and management by means of video communication and digital communication channels. The agenda and all documents relating to the AGM were published today on the company’s website. The general partner and the Supervisory Board propose a dividend of EUR 0.50 per share and thus on the prior year’s level to the Annual General Meeting. Based on the 52.3 million shares currently entitled to a dividend payment, the planned total payout would be around EUR 26.1 million. The payout ratio as of the adjusted consolidated net income 2022 of EUR 94.1 million would be around 28 percent. "We are happy to report a successful year 2022 to our shareholders and to provide an attractive outlook for 2023. CGM is excellently positioned for future profitable growth, and we want our shareholders to participate in our positive development." comments Michael Rauch, Spokesman for the Managing Directors and CFO. The preliminary figures for the financial year 2022 and the guidance for 2023 were already announced on February 9, 2023. The full Annual Report is available on the company's website under Investor Relations since March 24, 2023.
About CompuGroup Medical SE & Co. KGaA CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 1.130 billion in 2022, its software products are designed to support all medical and organizational activities in doctors’ offices, pharmacies, laboratories, hospitals and social welfare institutions. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical’s services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other healthcare professionals in inpatient and outpatient facilities. With locations in 20 countries and products in 60 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. More than 9,200 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.
03.04.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | CompuGroup Medical SE & Co. KGaA |
| Maria Trost 21 | |
| 56070 Koblenz | |
| Germany | |
| Phone: | +49 (0)160 3630362 |
| Fax: | +49 (0)261 8000 3200 |
| E-mail: | investor@cgm.com |
| Internet: | www.cgm.com |
| ISIN: | DE000A288904 |
| WKN: | A28890 |
| Indices: | SDAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1600017 |
| End of News | EQS News Service |
|
|
1600017 03.04.2023 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.